.png)
CooperSurgical, part of The Cooper Companies, is a global leader in women’s health and reproductive medicine. Its CooperGenomics division focuses on advanced genetic testing services, including preimplantation genetic testing (PGT), pathology, and embryo diagnostics. Operating across high-complexity laboratories in the United States, United Kingdom, and Japan, CooperGenomics supports clinicians and patients with precision-driven insights that are critical to treatment decisions and outcomes.
LEAP was engaged to support the digital transformation of CooperGenomics’ laboratory operations, with a focus on designing and implementing a unified Laboratory Information Management System (LIMS) and enabling robotic automation across global sites
Defined a global LIMS strategy and unified system architecture to support complex PGT workflows across geographies.
Defined end-to-end laboratory workflows across multiple complex assays supporting embryo and carrier testing.
Established data models, lineage tracking, and API integration frameworks.
Aligned cross-functional stakeholders across lab operations, bioinformatics, and technology teams.
Designed standardized workflows and automation to reduce variability, increase throughput, and ensure consistent operations across all labs.
Implemented unified workflows across US, UK, and Japan laboratory environments.
Integrated robotic instrumentation and automated data exchange between systems.
Reduced manual touchpoints and improved accuracy across sample processing and sequencing pipelines.
Led configuration, testing, and deployment of the Sapio LIMS platform to enable validation readiness, compliance, and scalability.
Delivered a validated, production-ready LIMS platform supporting global operations.
Supported user acceptance testing, validation processes, and system cutover.
Enabled a scalable foundation for future assay expansion and increased testing volume.
.svg)
.svg)
